Publication | Closed Access
A Phase I Study of Periocular Topotecan in Children with Intraocular Retinoblastoma
53
Citations
24
References
2009
Year
The dose limiting toxicity was not reached. Up to 2 mg of periocular topotecan could be given safely, but further studies are necessary to determine its effect on retinoblastoma (ClinicalTrials.gov number, NCT00460876).
| Year | Citations | |
|---|---|---|
Page 1
Page 1